
AVAH Stock Forecast & Price Target
AVAH Analyst Ratings
Bulls say
Aveanna Healthcare Holdings Inc demonstrated strong financial performance, with revenue from its Private Duty Services (PDS) segment reaching $514.4 million, a 25.6% increase year-over-year, significantly exceeding expectations. The Home Health & Hospice (HHH) segment also showed robust growth, generating $62.4 million in revenue, which marks a 15.3% increase compared to the previous year, driven by a rise in total admissions. Furthermore, improved financial flexibility is indicated by a cash flow increase and a strong spread of $12.62, up 23.0% year-over-year, alongside raised revenue guidance of more than $2.375 billion, reflecting a positive outlook for the company.
Bears say
The analysis indicates several fundamental challenges facing Aveanna Healthcare Holdings Inc., contributing to a negative outlook on its stock. Key concerns include potential reimbursement pressures and increased competition, which could hinder the company's ability to achieve anticipated organic growth and successfully integrate acquisitions. Additionally, high leverage and ongoing labor headwinds are projected to contribute to a 10% reduction in FY26 adjusted EBITDA estimates, alongside a consistent decline in gross margins year-over-year.
This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.
AVAH Analyst Forecast & Price Prediction
Start investing in AVAH
Order type
Buy in
Order amount
Est. shares
0 shares